Skip to main content
US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
12 September 2023, Geneva/New York – Next week, world leaders meet for the second-ever global tuberculosis (TB) High-Level Meeting at the United Natio...
Akses ke perubatan
Tuberkulosis
Doctors Without Borders calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug, main patent expires in India today
India
Doctors Without Borders calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug, main patent expires in India today
Recent deal offering controlled generics access in limited countries does not go far enough.
Tuberkulosis
Akses ke perubatan
Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB
Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB
Doctors Without Borders /Médecins Sans Frontières(MSF) called on governments and donors today to speed up access to new, shorter, safer and more effec...
Akses ke perubatan
Tuberkulosis
HIV/AIDS in the DRC: Behind the progress, huge challenges remain
DR Congo
HIV/AIDS in the DRC: Behind the progress, huge challenges remain
In 2002, Doctors Without Borders / Médecins Sans Frontières (MSF) teams opened the first outpatient treatment centre offering free care to people livi...
HIV/AIDS
Akses ke perubatan
Belarus: Three hundred patients start innovative TB treatment programme
Belarus
Belarus: Three hundred patients start innovative TB treatment programme
“On the tenth day of my treatment, I could tell that something was wrong with my ears,” says Maria. “The drugs were affecting my auditory nerve. Havin...
Tuberkulosis
Akses ke perubatan
Infectious diseases
Doctors Without Borders and its partners’ TB PRACTECAL Clinical Trial will be included in the updated WHO global guidance on treatment
Doctors Without Borders and its partners’ TB PRACTECAL Clinical Trial will be included in the updated WHO global guidance on treatment
Geneva, 3 May2022 - Doctors Without Borders / Médecins Sans Frontières (MSF) are pleased that,having shared the results of TBPRACTECAL, our clinical t...
Akses ke perubatan
Tuberkulosis
Northern Syria: Ineffective COVID-19 vaccine system has hampered vaccination
Syria
Northern Syria: Ineffective COVID-19 vaccine system has hampered vaccination
The COVID-19 vaccine Humanitarian Buffer (HB) is failing its mission to support populations hit by the pandemic and struggling to have access to immun...
Akses ke perubatan
Vaksin Covid-19
Malaysia: Safe and affordable healthcare for all essential in health system reform
Malaysia
Malaysia: Safe and affordable healthcare for all essential in health system reform
Doctors Without Borders / Medecins Sans Frontieres (MSF) welcomes Health Minister Khairy Jamaluddin’s proposal to reform the country’s health system a...
Pelarian
Akses ke perubatan
Doctors Without Borders response to license between Pfizer and Medicines Patent Pool for new COVID-19 treatment Paxlovid
Doctors Without Borders response to license between Pfizer and Medicines Patent Pool for new COVID-19 treatment Paxlovid
Pfizer recently shared positive interim results for its COVID-19 oral antiviral investigational candidate PF-07321332 in combination with ritonavir (P...
Akses ke perubatan